Godavari Biorefineries Limited — Q1FY27 Earnings Call Summary

GODAVARIB · Q1FY27 · Filed 13 Aug 2026

Key Takeaways

• Ethanol blending demand outlook positive with E20 rollout and draft E85/E100 guidelines
• Q1 FY27 revenue from operations grew 4.6% y-y to INR558 Cr; total income INR560 Cr +4.9% y-y
• Integrated sugar, cogeneration, ethanol segment EBITDA loss widened to INR14.6 Cr due to feedstock cost and manufacturing pressures
• Drug discovery: filed for preliminary efficacy trials for TNBC molecule; trials expected Q3 FY27 pending approvals
• Commissioned 200 KLPD grain-based distillery, total distillery capacity now 800 KLPD; evaluating 160 KLPD fungible capacity addition
• Bio-based chemicals revenue up 19.4% y-y to INR169 Cr; EBITDA +53% to INR19.2 Cr; margin expanded to 11.4%
• Debottlenecking bio-based chemicals with INR25 Cr investment; targeting INR240 Cr quarterly sales post expansion
• Multiple analyst queries on DME pilot trials, bio-butanol commercialization, and sugar vs ethanol production mix
• Closing sugar inventory approx 65,000 tons; mix of long-term contracts and open market
• Focus on integrated biorefinery model with feedstock and product flexibility to manage volatility and growth

📄 Source: View original transcript (PDF)

Summary generated by AI from the official transcript filed on BSE/NSE. Not investment advice.